Sign up to save your podcasts
Or
Share The Lancet Respiratory Medicine: January 27, 2014
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Lancet Respiratory Medicine: January 27, 2014
Victor Ortega discusses the effect of rare ADRB2 variants of risk on severe asthma exacerbations in patients receiving treatment with LABAs.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
View all episodes
By The Lancet Group
5
11 ratings
Victor Ortega discusses the effect of rare ADRB2 variants of risk on severe asthma exacerbations in patients receiving treatment with LABAs.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
More shows like The Lancet Respiratory Medicine in conversation with
View all
JAMA Editors' Summary
131 Listeners
This Week in Virology
2,052 Listeners
Thorax Podcast
3 Listeners
NEJM This Week
325 Listeners
Out of the Blue: An AJRCCM Podcast
34 Listeners
JAMA Clinical Reviews
496 Listeners
The Lancet Voice
23 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
20 Listeners
The Lancet Child & Adolescent Health in conversation with
0 Listeners
The Lancet Digital Health in conversation with
0 Listeners
The Lancet Global Health in conversation with
2 Listeners
The Lancet Oncology in conversation with
1 Listeners
The Lancet Psychiatry in conversation with
0 Listeners
The Lancet in conversation with
1 Listeners
The Lancet Haematology in conversation with
0 Listeners
The Ezra Klein Show
15,335 Listeners
The Lancet Gastroenterology & Hepatology in conversation with
0 Listeners
The Lancet Diabetes & Endocrinology in conversation with
1 Listeners
The Lancet Infectious Diseases in conversation with
0 Listeners
The Lancet Public Health in conversation with
1 Listeners
The Lancet Microbe in conversation with
0 Listeners
In conversation with...
0 Listeners
eBioMedicine in conversation with
0 Listeners
ID:IOTS - Infectious Disease Insight Of Two Specialists
24 Listeners
eClinicalMedicine in conversation with
0 Listeners
The Lancet Rheumatology in conversation with
0 Listeners
The Lancet Regional Health in conversation with
0 Listeners
The Rest Is Entertainment
819 Listeners
The Rest Is Politics: US
2,300 Listeners
The Lancet Regional Health Americas in conversation with
0 Listeners